YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCFR0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,886
Award facts
- Contract value 100% obligated
- $18,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,886.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (Yellow Fever Vaccine) in single-dose vials. The delivery order, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, was made without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award was funded by the Defense Logistics Agency and represents a routine pharmaceutical supply requirement for Department of Defense medical operations.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for diverse pharmaceutical products and medical consumables to support military healthcare facilities globally, leveraging DMS Pharmaceutical Group's established performance capabilities in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCFR0?
SPE2DR26FCFR0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FCFR0 worth?
The government has obligated $18,886 on SPE2DR26FCFR0.
Is contract SPE2DR26FCFR0 an order under another contract?
Yes. SPE2DR26FCFR0 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFR0 competed?
The extent of competition for SPE2DR26FCFR0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award